Le Lézard
Classified in: Health
Subjects: LAW, PLW

Puritan Secures Another Legal Victory Against Copan in Sweden


Italian competitor's infringement claims rebutted once again, marking its sixth defeat to date

GUILFORD, Maine, Jan. 4, 2023 /PRNewswire/ -- Today, Puritan Medical Products?the world's most trusted manufacturer of swabs and specimen collection and transport devices ?is proud to celebrate yet another affirmation of patent law, this time in Sweden. The Swedish patent lawsuit filed by Italian swab-maker Copan Italia S.p.A. hit a dead end earlier this month, with the Swedish Court of Appeals confirming that Puritan's flocked swabs do not infringe any claims of Copan's European Patent that supposedly protects the Italian company's core flocked swab technology.

Copan launched a patent offensive against Puritan distributor Svenska LABFAB in Sweden back in April 2019, after losing a competitive bid in Sweden. The Italian company announced the Swedish lawsuit during a trade show in the Netherlands, handing out flyers claiming "that Svenska LABFAB has committed a willful infringement of the patent covering COPAN's core flocked swab technology." By June 2020, however, the Swedish courts sided with LABFAB and handed Copan a resounding defeat. LABFAB successfully defeated the infringement claims and even earned legal fees for its efforts.

Later that year, in November 2020, Puritan similarly defeated the Italian competitor in a string of German lawsuits and appeals, also earning legal fees. Fast forward to 2022, and Copan suffered another defeat at the hands of the International Trade Commission (ITC) in Washington, D.C. In that case, Copan accused rival Chinese swab makers of infringing its patents, only for the claims to be denied by an ITC judge. Copan has now lost six lawsuits in which it asserted flocked swab patent infringement.

"Heading into 2023, Puritan's hard-working team can celebrate yet another legal victory that upholds patent law," said Bob Shultz, President and CFO at Puritan. "Copan's latest defeat is a strong message to our entire industry that good-faith business practices are paramount in this day and age. We are happy that this most recent distraction is now behind us, as we look ahead to doing right by our customers in the new year."

To schedule an interview, please contact Virginia Templet, [email protected].

Logo - https://mma.prnewswire.com/media/703607/Puritan_Medical_Logo.jpg


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: